SCHEMBL3950982

SCHEMBL3950982

CCCCCCCC(=O)CO

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.65
MAPT P10636 1/20 0.65
CES2 O00748 4/20 0.62
CES1 P23141 4/20 0.62
GPR84 Q9NQS5 7/20 0.59
PPARG P37231 7/20 0.59
PPARD Q03181 7/20 0.59
PPARA Q07869 7/20 0.59
HDAC11 Q96DB2 5/20 0.59
TSHR P16473 5/20 0.59
PTPN1 P18031 3/20 0.59
ALDH1A1 P00352 3/20 0.59
TLR2 O60603 2/20 0.59
TDP1 Q9NUW8 2/20 0.59
FABP4 P15090 2/20 0.59
SLC22A6 Q4U2R8 1/20 0.59
SLC22A8 Q8TCC7 1/20 0.59
MEN1 O00255 1/20 0.59
ESR1 P03372 1/20 0.59
ALOX15 P16050 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30279838 1.00 KMT2A (0.65) KMT2AMAPTCES2CES1GPR84
SCHEMBL9730057 1.00 KMT2A (0.65) KMT2AMAPTCES2CES1GPR84
SCHEMBL300211 1.00 KMT2A (0.65) KMT2AMAPTCES2CES1GPR84
SCHEMBL10807672 1.00 KMT2A (0.65) KMT2AMAPTCES2CES1GPR84
SCHEMBL20067018 1.00 KMT2A (0.65) KMT2AMAPTCES2CES1GPR84
SCHEMBL14917692 1.00 KMT2A (0.65) KMT2AMAPTCES2CES1GPR84
SCHEMBL11246992 1.00 KMT2A (0.65) KMT2AMAPTCES2CES1GPR84
SCHEMBL2528166 1.00 KMT2A (0.65) KMT2AMAPTCES2CES1GPR84
SCHEMBL5873457 1.00 KMT2A (0.65) KMT2AMAPTCES2CES1GPR84
SCHEMBL28477653 1.00 KMT2A (0.65) KMT2AMAPTCES2CES1GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240224999-A1 METABOLIC INHIBITORS FOR CONTROLLING BIOFILM MC US 3 LLC (US) 2024-07-11 US disclosed
US-20230183640-A1 METABOLIC INHIBITORS WITH EFFICACY FOR INHIBITING SULFIDE PRODUCTION IN HARSH ENVIRONMENTS LANXESS CORPORATION 2023-06-15 US disclosed
EP-2051955-B1 PRODUCTION OF ALPHA HYDROXY KETONES VIA CARBENE CATALYZED POLE REVERSAL REACTION OF ALDEHYDES EVONIK DEGUSSA GMBH (DE) 2016-08-31 EP disclosed
EP-2051955-B1 PRODUCTION OF ALPHA HYDROXY KETONES VIA CARBENE CATALYZED POLE REVERSAL REACTION OF ALDEHYDES EVONIK DEGUSSA GMBH (DE) 2016-08-31 EP disclosed
WO-2013157651-A1 PROCESS FOR PRODUCING ALPHA-HYDROXYKETONE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-10-24 WO disclosed
US-20120000533-A1 PHOTOELECTRIC CONVERSION DEVICE COMPRISING HYDROXAMIC ACID OR A SALT THEREOF AS ADDITIVE AND PROCESS FOR PRODUCING SAME BASF SE (DE) 2012-01-05 US disclosed
US-20090306163-A1 TOPICAL COMPOSITIONS COMPRISING IMIDAZOLIDINEDIONE ANALOGS AND THEIR USE TO TREAT OR PREVENT THE APPEARANCE OF SKIN WRINKLING LIPKIN PAMELA RENEE 2009-12-10 US disclosed
EP-2051955-A1 PRODUCTION OF ALPHA HYDROXY KETONES VIA CARBENE CATALYZED POLE REVERSAL REACTION OF ALDEHYDES Evonik Degussa GmbH (DE) 2009-04-29 EP disclosed
US-7504542-B2 Preparation of α-hydroxy ketones via carbene-catalyzed umpolung reaction of aldehydes EVONIK DEGUSSA GMBH (DE) 2009-03-17 US disclosed
US-7504542-B2 Preparation of α-hydroxy ketones via carbene-catalyzed umpolung reaction of aldehydes EVONIK DEGUSSA GMBH (DE) 2009-03-17 US disclosed
US-7504542-B2 Preparation of α-hydroxy ketones via carbene-catalyzed umpolung reaction of aldehydes EVONIK DEGUSSA GMBH (DE) 2009-03-17 US disclosed
US-20080051608-A1 Preparation of alpha-hydroxy ketones via carbene-catalyzed umpolung reaction of aldehydes DEGUSSA GMBH (DE) 2008-02-28 US disclosed
US-20080051608-A1 Preparation of alpha-hydroxy ketones via carbene-catalyzed umpolung reaction of aldehydes DEGUSSA GMBH (DE) 2008-02-28 US disclosed
US-20080051608-A1 Preparation of alpha-hydroxy ketones via carbene-catalyzed umpolung reaction of aldehydes DEGUSSA GMBH (DE) 2008-02-28 US disclosed
WO-2008019927-A1 PRODUCTION OF ALPHA HYDROXY KETONES VIA CARBENE CATALYZED POLE REVERSAL REACTION OF ALDEHYDES EVONIK DEGUSSA GMBH (DE) 2008-02-21 WO disclosed
WO-2008019927-A1 PRODUCTION OF ALPHA HYDROXY KETONES VIA CARBENE CATALYZED POLE REVERSAL REACTION OF ALDEHYDES EVONIK DEGUSSA GMBH (DE) 2008-02-21 WO disclosed
US-6861402-B1 Pro-fragrances THE PROCTER & GAMBLE COMPANY (US) 2005-03-01 US disclosed
EP-0108627-A2 Cephalosporin derivatives and process for producing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1984-05-16 EP disclosed
EP-0046270-A1 Novel derivatives of bio-affecting phenolic compounds and pharmaceutical composition containing them INTERx RESEARCH CORPORATION (US) 1982-02-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080051608-A1 Preparation of alpha-hydroxy ketones via carbene-catalyzed umpolung reaction of aldehydes HACL2, PCCA, ECI1 KMT2A 3477/4885MAPT 4034/4885CES2 915/4885
US-20090306163-A1 TOPICAL COMPOSITIONS COMPRISING IMIDAZOLIDINEDIONE ANALOGS AND THEIR USE TO TREAT OR PREVENT THE APPEARANCE OF SKIN WRINKLING CUTA, COL14A1, PDE7B KMT2A 3662/4885MAPT 2404/4885CES2 3402/4885
US-20240224999-A1 METABOLIC INHIBITORS FOR CONTROLLING BIOFILM RIMKLA, HDHD5, SCD KMT2A 1215/4885MAPT 3340/4885CES2 614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.